SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001213900-20-027736
Filing Date
2020-09-22
Accepted
2020-09-22 08:58:50
Documents
3
Effectiveness Date
2020-09-22

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea127175-s3mef_protara.htm S-3MEF 47476
2 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea127175ex23-1_protara.htm EX-23.1 3159
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea127175ex23-2_protara.htm EX-23.2 2096
  Complete submission text file 0001213900-20-027736.txt   53935
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-248964 | Film No.: 201187987
SIC: 2836 Biological Products, (No Diagnostic Substances)